Evaluation of Mass Balance and Absolute Bioavailability of GLPG3667
Clinical trial NCT05335447 · COMPLETED
Trial details
- NCT number
- NCT05335447
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-19
- Primary completion
- 2022-06-03
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.